Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,812 | 651 | 99.8% |
| Education | $15.64 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,237 | 79 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,207 | 78 | $0 (2024) |
| Lilly USA, LLC | $855.56 | 58 | $0 (2024) |
| Novo Nordisk Inc | $757.24 | 42 | $0 (2024) |
| PFIZER INC. | $735.24 | 48 | $0 (2024) |
| GlaxoSmithKline, LLC. | $659.68 | 45 | $0 (2024) |
| ABBVIE INC. | $641.25 | 60 | $0 (2024) |
| Merck Sharp & Dohme LLC | $517.28 | 40 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $486.31 | 44 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $361.91 | 20 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,753 | 101 | AstraZeneca Pharmaceuticals LP ($459.91) |
| 2023 | $1,700 | 101 | Novo Nordisk Inc ($270.42) |
| 2022 | $1,336 | 87 | Boehringer Ingelheim Pharmaceuticals, Inc. ($222.13) |
| 2021 | $537.01 | 38 | Boehringer Ingelheim Pharmaceuticals, Inc. ($163.35) |
| 2020 | $461.59 | 26 | Boston Scientific Corporation ($116.27) |
| 2019 | $1,581 | 110 | AstraZeneca Pharmaceuticals LP ($282.23) |
| 2018 | $881.36 | 68 | AstraZeneca Pharmaceuticals LP ($152.11) |
| 2017 | $1,578 | 123 | Boehringer Ingelheim Pharmaceuticals, Inc. ($297.54) |
All Payment Transactions
654 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: Diabetes | ||||||
| 12/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: Diabetes | ||||||
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Respiratory | ||||||
| 11/26/2024 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/18/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: RESPIRATORY | ||||||
| 11/17/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: VACCINES | ||||||
| 11/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.98 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Respiratory | ||||||
| 11/01/2024 | Merck Sharp & Dohme LLC | LAGEVRIO (Drug) | Food and Beverage | In-kind items and services | $25.27 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/21/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $35.04 | General |
| Category: ONCOLOGY | ||||||
| 10/17/2024 | SANOFI PASTEUR INC. | FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE (Biological) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Vaccines | ||||||
| 10/11/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: DERMATOLOGY | ||||||
| 10/09/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Obesity | ||||||
| 10/07/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Respiratory | ||||||
| 10/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.49 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: VACCINES | ||||||
| 09/27/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $8.18 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/26/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: PAIN | ||||||
| 09/24/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Respiratory | ||||||
| 09/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,070 | 1,418 | $337,515 | $106,957 |
| 2022 | 18 | 1,100 | 1,407 | $315,448 | $97,201 |
| 2021 | 20 | 1,378 | 1,846 | $256,791 | $137,736 |
| 2020 | 22 | 1,307 | 1,839 | $237,081 | $117,487 |
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 3 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2021 | 26 | 26 | $634.00 | $113.88 | 18.0% |
| 96127 | Brief emotional or behavioral assessment | Office | 2021 | 21 | 21 | $525.00 | $69.30 | 13.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 262 | 590 | $118,000 | $47,328 | 40.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 163 | 339 | $47,460 | $19,718 | 41.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 89 | 89 | $12,460 | $11,612 | 93.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2020 | 46 | 46 | $9,200 | $8,780 | 95.4% |
| 99497 | Advance care planning by the physician or other qualified health care professional | Office | 2020 | 64 | 64 | $8,000 | $5,352 | 66.9% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2020 | 16 | 19 | $8,550 | $4,195 | 49.1% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 56 | 57 | $3,990 | $3,470 | 87.0% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 26 | 26 | $2,990 | $2,975 | 99.5% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2020 | 121 | 121 | $3,025 | $2,514 | 83.1% |
| G0444 | Annual depression screening, 15 minutes | Office | 2020 | 120 | 120 | $3,000 | $2,483 | 82.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 27 | 34 | $3,752 | $1,919 | 51.1% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2020 | 12 | 12 | $3,600 | $1,906 | 52.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 70 | 71 | $2,485 | $1,352 | 54.4% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2020 | 43 | 43 | $2,150 | $1,250 | 58.2% |
| G0180 | Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem | Office | 2020 | 12 | 15 | $1,290 | $716.96 | 55.6% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 40 | 43 | $2,924 | $638.14 | 21.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 26 | 26 | $910.00 | $493.40 | 54.2% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 14 | 14 | $700.00 | $274.12 | 39.2% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2020 | 17 | 18 | $450.00 | $202.24 | 44.9% |
| 96127 | Brief emotional or behavioral assessment | Office | 2020 | 44 | 44 | $1,100 | $126.18 | 11.5% |
| 81002 | Urinalysis, manual test | Office | 2020 | 22 | 31 | $620.00 | $107.11 | 17.3% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2020 | 17 | 17 | $425.00 | $74.10 | 17.4% |
About Dr. Christopher Horn, D.O
Dr. Christopher Horn, D.O is a Family Medicine healthcare provider based in Rockaway, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1821095605.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Horn, D.O has received a total of $9,828 in payments from pharmaceutical and medical device companies, with $1,753 received in 2024. These payments were reported across 654 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($9,812).
As a Medicare-enrolled provider, Horn has provided services to 4,855 Medicare beneficiaries, totaling 6,510 services with total Medicare billing of $459,380. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Rockaway, NJ
- Active Since 07/07/2005
- Last Updated 12/10/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1821095605
Products in Payments
- JARDIANCE (Drug) $1,168
- FARXIGA (Drug) $700.56
- VRAYLAR (Drug) $440.37
- REXULTI (Drug) $361.91
- BREZTRI (Drug) $343.42
- ANORO (Drug) $292.49
- TRELEGY ELLIPTA (Drug) $286.66
- JANUVIA (Drug) $262.17
- PREVNAR 20 (Biological) $246.05
- Wegovy (Drug) $239.58
- TRADJENTA (Drug) $232.13
- Ozempic (Drug) $220.80
- Trintellix (Drug) $202.25
- INVOKANA (Drug) $201.10
- CHANTIX (Drug) $199.72
- UBRELVY (Drug) $177.39
- XARELTO (Drug) $164.43
- TRULICITY (Drug) $156.54
- NURTEC ODT (Drug) $150.66
- STIOLTO RESPIMAT (Drug) $144.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Rockaway
Christopher Heitzman, D.o, D.O
Family Medicine — Payments: $1,924
Dr. Olympia Sophias, D.o, D.O
Family Medicine — Payments: $467.89
Dr. Aadya Sharma, Md, MD
Family Medicine — Payments: $289.80
Dr. Oluwatoyin Fapohunda-Adekola, Md, MD
Family Medicine — Payments: $190.96
Dr. Ian Brodrick, M.d, M.D
Family Medicine — Payments: $145.14
Christine Sedlacek, Md, MD
Family Medicine — Payments: $104.64